Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

September 30, 2008

Study Completion Date

November 30, 2008

Conditions
Pneumonia
Interventions
DRUG

ceftazidime and amikacin

Nebulized ceftazidime 15 mg/kg/3h during 8 days and nebulized amikacin 25 mg/kg/day during 3 days

DRUG

ceftazidime and amikacin

Intravenous infusion of ceftazidime 30 mg/kg over 30 min followed by continuous infusion 90 mg/kg/day during 8 days and intravenous infusion of amikacin 15 mg/kg/day over 30 min during 3 days

Trial Locations (1)

75013

Intensive care unit, Department of anesthesiology, La pitie-Salpetriere hospital, Paris

All Listed Sponsors
lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT00786305 - Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia | Biotech Hunter | Biotech Hunter